E
Athira Pharma, Inc. ATHA
$0.36 $0.01885.51% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -20.47% -21.65% -21.08% -18.69% -2.57%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -37.11% -23.86% -6.31% 11.92% 24.51%
Operating Income 37.11% 23.86% 6.31% -11.92% -24.51%
Income Before Tax 31.37% 17.62% 9.38% -5.30% -13.38%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 31.37% 17.62% 9.38% -5.30% -13.38%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 31.37% 17.62% 9.38% -5.30% -13.38%
EBIT 37.11% 23.86% 6.31% -11.92% -24.51%
EBITDA 37.39% 24.04% 6.36% -12.00% -24.69%
EPS Basic 32.17% 18.55% 10.26% -4.47% -12.51%
Normalized Basic EPS 36.79% 23.22% 4.42% -16.58% -26.07%
EPS Diluted 32.17% 18.55% 10.26% -4.47% -12.51%
Normalized Diluted EPS 36.79% 23.22% 4.42% -16.58% -26.07%
Average Basic Shares Outstanding 1.42% 1.21% 0.98% 0.83% 0.80%
Average Diluted Shares Outstanding 1.42% 1.21% 0.98% 0.83% 0.80%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --